Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025)

Zhengye Biotechnology Holding has reported Total Debt over the past 3 years, most recently at $10.4 million for Q4 2025.

  • Quarterly Total Debt fell 5.49% to $10.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, down 5.49% year-over-year, with the annual reading at $10.3 million for FY2025, 5.22% down from the prior year.
  • Total Debt was $10.4 million for Q4 2025 at Zhengye Biotechnology Holding, up from $677438.4 in the prior quarter.
  • Over five years, Total Debt peaked at $11.1 million in Q4 2023 and troughed at $677438.4 in Q2 2025.
  • The 3-year median for Total Debt is $10.7 million (2024), against an average of $8.3 million.
  • Year-over-year, Total Debt fell 1.03% in 2024 and then dropped 5.49% in 2025.
  • A 3-year view of Total Debt shows it stood at $11.1 million in 2023, then decreased by 1.03% to $11.0 million in 2024, then decreased by 5.49% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Total Debt are $10.4 million (Q4 2025), $677438.4 (Q2 2025), and $11.0 million (Q4 2024).